CHEK1 and cancer: In contrast, <i>KRAS<sup>G12V</sup></i><sup>/+</sup> cells exhibited hypersensitivity to inhibitors for the ATR-Chk1 checkpoint signalling axis and to nucleoside analogues commonly used to treat cancers and viral infections.